Study: Professional medication review is a must when older adults want to scale back meds
By
Kristen Fischer
Jul 29, 2024
Many older adults want to cut back on taking multiple medications, or polypharmacy, but they need to talk to a clinician or pharmacist first, authors of a new report say.
Study looks at co-use of CYP2D6-metabolizing opioids, antidepressants in seniors
Jul 22, 2024
CYP2D6-inhibiting antidepressants were linked to worse outcomes than CYP2D6-neutral antidepressants when used with CYP2D6-metabolizing opioids.
Nurse practitioners no more likely than doctors to prescribe inappropriately
Oct 23, 2023
Nurse practitioners were overrepresented among clinicians with the highest and lowest rates of inappropriate prescribing.
Benzodiazepines not tied to higher dementia risk in older adults
Jul 16, 2024
Potential class-dependent associations may exist, however.
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
Extended-release oral ketamine effective for treatment-resistant depression
Jul 17, 2024
Excellent tolerability was seen, with no changes in blood pressure, minimal reports of sedation and minimal dissociation.
Biden looks to boost supply chain for vaccines and other medicines
By
Kathleen Steele Gaivin
Nov 29, 2023
President Biden on Monday said he plans to use the Defense Production Act to make more “essential medicines” in America in an effort to mitigate drug shortages and curb inflation.
Loneliness linked to use of high-risk meds in seniors
Aug 06, 2021
Loneliness was associated with the use of NSAIDs, pain medicine, sedatives, anti-anxiety meds and antidepressants.
Pfizer restarts production plant in North Carolina following tornado damage in July
Sep 26, 2023
Most of the damage happened at the plant’s storage facility rather than its medication production areas.
Inflation Reduction Act estimated to yield billions in drug savings
Feb 02, 2023
The ceiling prices for negotiation would have reduced Medicare prescription drug spending by ~5% if implemented from 2018 to 2020.